MLS Interns Katie McGraw and Cynthia Nnko Rotate Through Pathology
Following his Namesake in Shaping the Future of Clinical Pathology
Family and colleagues join the celebration.
It has been a little over a year since the Department of Pathology began its journey toward a renewed culture by implementing the FiSH! Philosophy. One of FiSH! core principles to bring well-being to our department is the concept of bringing joy to the workplace through forms of play. The MLabs Division put FiSH! Philosophy into action on July 25th as MLabs’ EMC2 team hosted the Happy Little Painters event. The goals were simple: be welcoming, make it accessible, and embrace the inner artist (no matter how large or small). Artist Elise Martin came in to teach members of the department how to paint as a wonderful experiment (outside of the lab!).
Help us welcome our new resident class, the Class of 2028!
Pathology Faculty and Staff Team up with Clinical Colleagues to Address Post-Surgical Kidney Injury
With the passage of the 21st Century Cures Act in 2021, patients were granted access to their medical test results without delay—often before their physician can review them. Pathology reports aren’t written with patients as a target audience and they contain complex medical terminology which can often lead to patient confusion and anxiety. To address this, researchers led by Cathryn Lapedis, M.D., M.P.H., of the Department of Pathology at Michigan Medicine, recently examined how a pathology explanation clinic, or PEC, could improve the experience of a small group of patients newly diagnosed with prostate cancer.
A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.
The findings appear in Cancer Cell.
Led by Arul Chinnaiyan, M.D., Ph.D., S.P. Hicks Professor of Pathology and director of the Michigan Center for Translational Pathology at Michigan Medicine, the research builds on previous work to find genetic vulnerabilities to treat transcription factor-driven cancers like prostate cancer.
The first annual Department of Pathology Art Competition has wrapped up with 13 fantastic pieces voted upon by the Wellness Committee!
Congratulations to Thomas Annesley, PhD, DABCC, Active Professor Emeritus of Clinical Chemistry on his recognition with an Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine from the Association for Diagnostics and Laboratory Medicine. This award is considered the premier award of the Association and is granted as a "lifetime achievement" award for contributions to the field of clinical chemistry. Individuals selected for this award have made significant contributions in all aspects of clinical chemistry, particularly service, education, and research; have achieved international stature and reputation by virtue of their efforts; and have demonstrated long standing service to the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), either at the grass roots, national and/or international levels.
Wednesday, July 17, 2024
Wednesday, July 17, 2024
Congratulations to Drs. Stephanie Skala, assistant professor of genitourinary, gynecologic, and surgical pathology and director of surgical pathology, and Jensyn Cone Sullivan, assistant professor of transfusion medicine, director of blood bank, and incoming director of the transfusion medicine fellowship program, on being named to the American Society for Clinical Pathology’s 40 Under Forty list!
Voting is now open on the top 40 nominees for selection to the Top Five, awarded in-person at The ASCP 2024 Annual Meeting! Click here to cast your votes – and vote daily through July 22nd, no login or email address required.
It is with great sadness that we share the sudden and unexpected passing of Liz McCloud, QA Coordinator for Satellite Phlebotomy. Liz started at Michigan Medicine-Pathology in 2006 and grew tremendously over the years from that of a Patient Care Tech Associate to Associate Supervisor, and in 2017 she assumed the role of Quality Assurance Coordinator.
To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.
“In pregnancy, the immune system does not reject the growing fetus, so we know there must be mechanisms active in the placenta. In cancer, it’s the same thing: the growing tumor is not rejected by the immune system. It means the cancer cells have developed strategies to suppress immune rejection, same as in pregnancy,” said Weiping Zou, M.D., Ph.D., professor of experimental pathology.
It’s a good thing in pregnancy – it allows the baby to grow. But in cancer, it means the tumor grows unchecked and treatments meant to stimulate an immune response are not effective.
Department of Pathology faculty member, Analisa DiFeo, PhD, has been named a 2024 Rogel Scholar by Michigan Medicine. The award supports exceptional faculty dedicated to achieving impact on cancer prevention, patient outcomes, and quality of life. Please join us in congratulating Dr. Analisa DiFeo on this prestigious award!
Administrative Intern from the U-M School of Public Health
Team Enhancing Care Daily at U-M Health.
Dr. Matthew Iyer's Transformation from Programmer to Pioneering Cancer Researcher
A Closer Look at Histotechs in the Diagnostic Pathway
The Division of Anatomic Pathology in the Michigan Medicine Department of Pathology offers grant funding for faculty and trainees to pursue research interests related to anatomic pathology that may not otherwise be funded. One of these internal AP grant-funded projects, led by first-author Eman Abdulfatah, MD and senior-author Rohit Mehra, MD, resulted in a recent cover story in Human Pathology entitled “Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies.”
"Congratulations to our graduating class! We look forward to following your successes as you navigate the dynamically changing field of pathology moving forward."
Pathology Takes Extra Steps to Ensure Patient Care Excellence
A Recap of the 2024 Meeting
The 2024 Conference Recap
Washtenaw Elementary Science Olympiad (WESO) is a volunteer organization and a division of the national Science Olympiad that coordinates a county-wide science competition amongst all elementary schools in Washtenaw County. Students choose their topic of interest in January and teams are formed with coaches (generally parent or teacher volunteers)... “I was roped into coaching Potions because my middle child was interested in competing in Potions and there was no coach,” explained Eric Jedynak, from Pathology Informatics. “I figured that I had some basic chemistry and laboratory experience, however, both were a little rusty.”
Congratulations to Koral Campbell, Molecular and Cellular Pathology graduate student on being awarded the Rogel Cancer Center’s TrEC Scholarships Graduate Student Scholarship 2024. Koral’s winning application on The Role of High Fat Diet in Clonal Hematopoiesis and Leukemogenesis earned her a $25,000 award to offset her tuition and fees for 2024. In addition, as a Rogel trainee, she will have priority access to training opportunities and additional scholarships.
The third annual Youth Summit at the Big House took place on Saturday, May 18th where students from across southeast Detroit gathered together to learn about healthcare, pathology, and more.
The Department of Pathology is sad to report the passing of another of our teammates, Hope Jones. Hope passed away in a car accident near her home on Sunday, May 12, 2024. A funeral memorial service will be Saturday, May 25, starting at 10:30am at Greater Love Tabernacle Church (17617 Plymouth Rd, Detroit, 48227).
With 20 subtypes of Renal Cell Carcinoma (RCC) listed by the World Health Organization in 2022, determining the specific type of RCC and the correct treatment protocol for patients can be daunting. Only seven of the 20 subtypes had been defined by specific molecular changes and the 20% of RCCs that are classified as non-clear cell RCCs (non-ccRCC), were primarily identified only by histopathologic features. The driving genetic changes had not been identified. A large multi-institutional team making up the Clinical Proteomic Tumor Analysis Consortium, including several researchers from Michigan Medicine’s Department of Pathology, performed multi-omics data analysis on 48 non-ccRCC and 103 ccRCC tumors as well as 101 normal adjacent tissues to study the genetic aberrations found in these tumor types. The findings of this research were recently published in Cell Reports Medicine, with Pathology’s Drs. Alexey Nesvizhskii and Saravana Mohan Dhanasekaran as senior authors and Dr. Ginny Xiaohe Li as first author.
Molecular and Cellular Pathology Graduate Student Michael Pitter successfully defended his PhD thesis on March 15, 2024, and officially became Michael Pitter, PhD, MS. Pitter completed his thesis research in the laboratory of Dr. Weiping Zou, the Charles B. de Nancrede Professor, Professor of Pathology and Surgery. Pitter’s thesis, “The Role of Peptidyl Arginine Deiminases in Regulating Anti-tumor Responses in Immune Cells” reports on his research which demonstrated that PAD2 and PAD4 enzymatic activity supported tumor growth and when inhibited, may serve as a novel target in the treatment of cancer. He also discovered that PAD4 citrullinated STAT1, controlling STAT1 transcriptional activity, and consequently, MHC-II expression and function in macrophages. This work featured multiple novel findings in macrophage biology which may be exploited for the treatment of cancer and was published in Cell Reports.
Please join us in congratulating Dr. Michael Pitter on the successful completion of his PhD!
In a manuscript published this week in JAMA Oncology, senior author Dr. Arul Chinnaiyan and members of the EDRN-PCA3 Study Group reported on their development and validation of a new 18-gene urine-based test for diagnosis of high-grade prostate cancer, MPS2. This test was initially developed in the Department of Pathology.
University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, MD, PhD, has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer. The SWI/SNF chromatin remodeling complex was previously found to facilitate access to enhancers that oncogenes can bind to, driving downstream gene expression in cancer. Degrading a subunit of this complex blocks the oncogenes [...]
Dr. Xiaobing Jin Shares His Story
The Clinical Pathology Symposium traveled to Danto Auditorium to showcase the Future of Pathology.
Healthcare disparities arise from multiple sources, some of which are cultural and rooted in historical biases. In health research, most study participants in the past have been of European descent. This delayed the identification of specific genetic differences that are found more frequently in non-Europeans, leading to misdiagnoses and inappropriate healthcare for those with these differences. One of these is the Duffy-null genotype leading to a Duffy-associated neutrophil count (DANC) that is lower than established reference ranges.
Dr. Asma Nusrat, F. Peyton Rous Professor and Director of Experimental Pathology, was awarded the 2024 Rous-Whipple award at the American Society for Investigative Pathology Annual Meeting on Saturday, April 20, 2024 in Baltimore, MD.
The ASIP Rous-Whipple Award is presented to a senior scientist with a distinguished career in research who has advanced the understanding of disease and has continued productivity at the time of the award, including impactful science [...]
Congratulations to Drs. Sarah Farran and Isabella Holmes who will be joining the Chief Resident team this upcoming academic year.
It is with profound sadness that we write about the unexpected passing of Dena Ryan, a member of our Pathology Informatics team who managed MediaLab for the Department of Pathology. Dena was born in Grand Rapids, Michigan and attended Lowell High School in Lowell, Michigan. Upon graduation, she obtained a bachelor’s degree in biology from Michigan Technological University in 1999, followed by a second bachelor’s degree in clinical laboratory sciences from Eastern Michigan University, before finding her way to Michigan Medicine’s Department of Pathology as a laboratory technician. She later transitioned to Pathology Informatics to support the MediaLab application as a business analyst.
The MCP team is proud to share the news that MCP student Gabrielle "Gabbi" Rozumek is the recipient of the 2024 Phyllis M. Wise Biomedical Sciences Graduate Student Award for Excellence in Service.
Gabbi is very passionate about and dedicated to serving her community. Since 2016, she has touched so many lives by serving in numerous and various capacities. A few of her efforts include:
An interdisciplinary team of researchers from across Michigan Medicine are focused on cutting-edge research to understand and address food allergies as members of the Mary H. Weiser Food Allergy Center. Nicholas Lukacs, PhD, the Godfrey Dorr Stobbe Professor of Pathology and Scientific Director of the Mary H. Weiser Food Allergy Center, and James R. Baker Jr., Ruth Dow Doan Professor of Biologic Nanotechnology and Director of the MHWFAC, were instrumental in founding the food allergy center in 2015 and in recruiting an exceptional team of researchers to the Center. One of their goals since the inception of the MHWFAC was to see it become recognized as one of the world’s elite research centers in its field. Recently, this goal was achieved when the National Institutes of Health awarded them one of just 10 seven-year CoFAR Cooperative Agreement Grants, recognizing the center’s exceptional ground-breaking research.
The American Association for Cancer Research recently released their 2024 Women in Cancer Research Scholar Awards and Rita A. Avelar, PhD, Postdoctoral Fellow in the DiFeo Laboratory, was one of just twelve women scholars awarded. This award is presented to early-career, meritorious female scientists at the AACR Annual Meeting, which will be held April 5-10, 2024, at the San Diego Convention Center in San Diego, California.
Dr. Rouba Ali-Fehmi Shares Her Global Passion
When thinking of Pathology, many people think of tests being run in a laboratory located “somewhere” or of autopsies being performed in the morgue. It is considered a field with little direct contact with patients, and this may be true for much of the department, but not all. One area of the department that has a lot of patient contact is our phlebotomy services. Phlebotomists are the people who collect blood at your bedside in the hospital or as you sit in a chair at a blood-drawing station. This high-demand career field is staffed with people whose goal is to make sure you have the best experience possible while having your blood drawn for testing.
One of these people is Jonathan Jennings, a phlebotomist at the Briarwood Clinics in Ann Arbor. Jennings has worked in this role for the past ten years, but phlebotomy was not his initial career choice in life. He occupied his younger years as a truck driver, making daily runs delivering goods around the Midwest. Years of long hours of sitting and bumping along in a semi took its toll on his body and by 40 years of age, his back could no longer endure the punishment. He had a choice to make…go on disability or find a career where his back issues could be accommodated.
Congratulations to Celina Kleer, MD, the Harold A. Oberman Collegiate Professor of Pathology and Director of Breast Pathology Research, on her election to the prestigious Association of American Physicians (AAP). The AAP is an honorary society dedicated to the advancement of scientific and practical medicine and admits only 70 new members to its rank each year. Election is highly selective and as described on their website, is “an honor extended to physicians with outstanding credentials in basic or translational biomedical research.” Kleer will be formally inducted into the AAP at their Annual Meeting in Chicago next month.
David Harro recalls 40 Years in Pathology
Dr. Daniel Boyer was recently announced as the Hematopathology Section Director. The hematopathology section consists of eleven faculty members who provide expert subspecialty diagnostic services and care for a large population of Michigan Medicine and MLabs patients using a variety of technologies including morphology, flow cytometry, cytogenetics, FISH, and molecular diagnostics. The service is anticipated to grow in volume and complexity as our integrated care network expands, and Dr. Boyer's leadership will be instrumental to our joint success.
Molecular and Cellular Pathology graduate student, Derek Dang, successfully defended his thesis, “Beyond the Warburg Effect: A study of metabolic alterations in malignancies of the posterior fossa” on January 19, 2024, becoming Dr. Derek Dang. Please join us in congratulating Dr. Derek Dang on his achievements.
If you are interested in learning more about the MCP Graduate Program, click here or email Dr. Jeff Rual at jrual@med.umich.edu.
Our Apheresis Unit’s faculty and staff take excellent care of the patients who come through their doors. Their dedication and compassion were recently recognized by Michigan Medicine’s Office of Patient Experience as they were awarded as one of the top two sites for performance on the patient experience metric for the past two quarters. Keith Gran, Chief Patient Experience Officer, and Devin Uppert, OPE Administrative Director presented members of the Apheresis Team with their award on March 19, 2024.